The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 13, 2022

Filed:

Oct. 28, 2021
Applicant:

S2 Genomics, Inc., Livermore, CA (US);

Inventors:

Stevan Bogdan Jovanovich, Livermore, CA (US);

Frank Zaugg, Redwood City, CA (US);

Kaiwan Chear, Livermore, CA (US);

Roger McIntosh, San Ramon, CA (US);

Nathan Pereira, Pleasanton, CA (US);

Assignee:

S2 GENOMICS, INC., Livermore, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
G01N 1/31 (2006.01); C12M 1/00 (2006.01); C12Q 1/6851 (2018.01); C12N 1/06 (2006.01); C12N 15/10 (2006.01); G01N 1/28 (2006.01);
U.S. Cl.
CPC ...
G01N 1/31 (2013.01); C12M 47/04 (2013.01); C12M 47/06 (2013.01); C12N 1/06 (2013.01); C12N 1/066 (2013.01); C12N 15/1003 (2013.01); C12Q 1/6851 (2013.01); G01N 1/286 (2013.01); G01N 2001/2866 (2013.01);
Abstract

A system, methods, and apparatus are described to collect and prepare single cells, nuclei, subcellular components, and biomolecules from specimens including tissues. The system can perform enzymatic and/or physical disruption of the tissue to dissociate it into single-cells or nuclei in suspension or subcellular components including nucleic acids. In some embodiments, the titer of dissociated cells is monitored at intervals and the viability determined. In some embodiments, the processing is adjusted according to the measurements of the titer and viability. In some embodiments, the single-cells or nuclei in suspension are washed and resuspended in the buffer or media of choice. In some embodiments, the conditions are chosen to produce nuclei. In other embodiments, the single-cells or nuclei are purified by affinity paramagnetic bead processing. In some embodiments, matched bulk nucleic acid to the single-cells is produced. In other embodiments, single-cell libraries, or nuclei libraries, or matched bulk libraries, or bulk libraries are produced. The single cells or nuclei can then be further processed by FACS, DNA sequencing, mass spectrometry, fluorescence, or other methods. In other embodiments, the tissue processing is integrated with an analytical system to produce a sample-to-answer system such as a tissue-to-genomics system.


Find Patent Forward Citations

Loading…